Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_assertion type Assertion NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_head.
- NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_assertion description "[GIP response to SFA ingestion is prolonged in nondiabetic patients with NASH and is correlated with liver disease, an unfavorable dynamic adipokine profile, and beta cell dysfunction, which provides a rationale for GIP antagonism in these subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_provenance.
- NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_assertion evidence source_evidence_literature NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_provenance.
- NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_assertion SIO_000772 19141695 NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_provenance.
- NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_assertion wasDerivedFrom befree-2016 NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_provenance.
- NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_assertion wasGeneratedBy ECO_0000203 NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_provenance.